FdaApplication
NDA 209510
Identifiers
- fda_app_no: NDA209510
Properties
| Property | Value |
|---|---|
| applicant_name | LXO IRELAND DESIGNATED ACTIVITY CO |
| application_type | NDA |
| approval_date | 2020-02-26 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BARHEMSYS | AMISULPRIDE | 10MG/4ML (2.5MG/ML) | SOLUTION;INTRAVENOUS |
| BARHEMSYS | AMISULPRIDE | 5MG/2ML (2.5MG/ML) | SOLUTION;INTRAVENOUS |
2 products